The role of complement in dendritic cell (DC) control of T-cell subsets

Levis, W.R.; Martiniuk, F.

Journal of Drugs in Dermatology Jdd 9(11): 1364-1366

2010


ISSN/ISBN: 1545-9616
PMID: 21061758
Document Number: 15580
This section of the Journal of Drugs in Dermatology (JDD) is dedicated to Dendreon's Provenge (Sipuleucel-T), the first therapeutic DC vaccine proven effective and approved by the United States (U.S.) Food and Drug Administration (FDA) for advanced cancer. This editorial will discuss three articles in this issue, their relationship to Provenge and the recent TH17-Treg subsets that are regulated by CD46.

Document emailed within 1 workday
Secure & encrypted payments

The role of complement in dendritic cell (DC) control of T-cell subsets